Cognizance Market Research

Global Biologics Market to Reach US$985.61 Billion by 2032, Driven by Chronic Disease Rise and Biotech Innovations at 8.37% CAGR

Biologics are the biological drug product that is produced from living organism or contain components of living organisms. Biologic drugs include a wide variety of …

Read More

Cognizance Market Research

Global Advanced Metastatic Pancreatic Cancer Market to Reach US$4.5 Billion by 2030, Driven by Immunotherapies and Personalized Medicine

Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These …

Read More

Cognizance Market Research

Global Drug Delivery System Market to Reach US$73.56 Billion by 2030, Driven by Chronic Diseases and Innovations in Targeted Therapies

Drug delivery systems refer to technologies that transport drugs throughout the body. These technologies include methods like swallowing a pill or injecting a vaccine. Drug …

Read More

Cognizance Market Research

Global Prostate Cancer Therapeutics Market to Reach US$23.23 Billion by 2030, Driven by Rising Prevalence and Advanced Hormonal Therapies

Prostate cancer, the most common non-cutaneous cancer globally, is primarily influenced by factors such as the aging population, sedentary lifestyles in industrialized countries, and the …

Read More

Cognizance Market Research

Global Acute Coronary Syndrome Market Advances with Innovative Detection Technologies and Novel Therapeutic Developments

Acute coronary syndrome is a group of diseases in which blood flow to the heart decreases or suddenly stops. When blood cannot flow to the …

Read More

Lungs Disease Therapeutics Market

Global Lung Disease Therapeutics Market to Reach US$106.9 Billion by 2030, Driven by Rising Respiratory Illnesses and Treatment Innovations

The market for pharmaceuticals and therapies used to control and treat respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pulmonary …

Read More

Monoclonal Antibody Therapeutics Market

Global Monoclonal Antibody Therapeutics Market to Reach US$501.5 Billion by 2030, Driven by Rising Chronic Diseases and R&D Investment

Monoclonal antibodies, commonly known as moAbs or mAbs, are lab-made proteins that function in human bodies similarly to antibodies. Your immune system includes antibodies as …

Read More